Identification and quantitation of amphetamines, cocaine, opiates, and phencyclidine in oral fluid by liquid chromatography-tandem mass spectrometry

Journal of Analytical Toxicology

Volumn 33, Issue 9, 2009, Pages 569-577

  Fritch, Dean ^a   Blum, Kristen ^a   Nonnemacher, Sheena ^a   Haggerty, Brenda J ^b   Sullivan, Matthew P ^c   Cone, Edward J ^d  

^a ORASURE TECHNOLOGIES INC   (United States)

^b DESALES UNIVERSITY   (United States)

^c KUTZTOWN UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; 3,4 METHYLENEDIOXYETHYLAMPHETAMINE; 3,4 METHYLENEDIOXYMETHAMPHETAMINE; 6 ACETYLCODEINE; AMPHETAMINE DERIVATIVE; BENZOYLECGONINE; COCAINE; CODEINE; DIHYDROCODEINE; HYDROCODONE; HYDROMORPHONE; ILLICIT DRUG; MORPHINE 6 ACETATE; MORPHINE DERIVATIVE; NORCODEINE; NORHYDROCODONE; NOROXYCODONE; OPIATE DERIVATIVE; OXYCODONE; OXYMORPHONE; PHENCYCLIDINE; PSEUDOEPHEDRINE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CLINICAL ARTICLE; DRUG ABUSE; DRUG DEPENDENCE TREATMENT; ELECTROSPRAY; HUMAN; LIQUID CHROMATOGRAPHY; QUALITY CONTROL; QUANTITATIVE ANALYSIS; REACTION ANALYSIS; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY;

EID: 74549219825     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.9.569     Document Type: Article

References (19)

1. F.M. Urry, G. Komaromy-Hiller, B. Staley, D.K. Crockett,M. Kushnir, G. Nelson, and R.E. Struempler. Nitrite adulteration of workplace urine drug-testing specimens I. Sources and associated concentrations of nitrite in urine and distinction between natural sources and adulteration. J. Anal. Toxicol. 22: 89-95 (1998).
2. E.J. Cone, R. Lange, and W.D. Darwin. In vivo adulteration: excess fluid ingestion causes false-negative marijuana and cocaine urine test results. J. Anal. Toxicol. 22: 460-473 (1998).
3. S.V. Kala, S.E. Harris, T.D. Freijo, and S. Gerlich. Validation of analysis of amphetamines, opiates, phencyclidine, cocaine, and benzoylecgonine in oral fluids by liquid chromatography-tandem mass spectrometry. J. Anal. Toxicol. 32: 605-611 (2008).
4. O.H. Drummer. Drug testing in oral fluid. Clin. Biochem. Rev. 27: 147-159 (2006).
5. E.J. Cone, J. Clarke, and L. Tsanaclis. Prevalence and disposition of drugs of abuse and opioid treatment drugs in oral fluid. J. Anal. Toxicol. 31: 424-433 (2007).
6. N. Samyn, M. Laloup, and G. De Boeck. Bioanalytical procedures for determination of drugs of abuse in oral fluid. Anal. Bioanal. Chem. 388: 1437-1453 (2007).
7. K. Pil and A. Verstraete. Current developments in drug testing in oral fluid. Ther. Drug Monit. 30: 196-202 (2008).
8. H.H. Maurer. Advances in analytical toxicology: the current role of liquid chromatography-mass spectrometry in drug quantification in blood and oral fluid. Anal. Bioanal. Chem. 381: 110-118 (2005).
9. M. Yonamine, N. Tawil, R.L. Moreau, and O.A. Silva. Solid-phase micro-extraction-gas chromatography-mass spectrometry and headspace-gas chromatography of tetrahydrocannabinol, amphetamine, methamphetamine, cocaine and ethanol in saliva samples. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 789: 73-78 (2003).
10. T. Gunnar, K. Ariniemi, and P. Lillsunde. Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry. J. Mass Spectrom. 40: 739-753 (2005).
11. E.J. Cone, L. Presley, M. Lehrer, W. Seiter, M. Smith, K. Kardos, D. Fritch, S. Salamone, and R.S. Niedbala. Oral fluid testing for drugs of abuse: positive prevalence rates by Intercept™ immunoassay screening and GC-MS-MS confirmation and suggested cutoff concentrations. J. Anal. Toxicol. 26: 541-546 (2002).
12. M. Concheiro, A. de Castro, O. Quintela, A. Cruz, and M. Lopez-Rivadulla. Determination of illicit and medicinal drugs and their metabolites in oral fluid and preserved oral fluid by liquid chromatography-tandem mass spectrometry. Anal. Bioanal. Chem. 391: 2329-2338 (2008).
13. M. Wood, M. Laloup, M.M. Ramirez Fernandez, K.M. Jenkins, M.S.Young, J.G. Ramaekers, G. De Boeck, and N. Samyn. Quantitative analysis of multiple illicit drugs in preserved oral fluid by solid-phase extraction and liquid chromatography-tandem mass spectrometry. Forensic Sci. Int. 150: 227-238 (2005).
14. E.L. Oiestad, U. Johansen, and A.S. Christophersen. Drug screening of preserved oral fluid by liquid chromatography-tandem mass spectrometry. Clin. Chem. 53: 300-309 (2007).
15. K.R. Allen, R. Azad, H.P. Field, and D.K. Blake. Replacement of immunoassay by LC tandem mass spectrometry for the routine measurement of drugs of abuse in oral fluid. Ann. Clin. Biochem. 42: 277-284 (2005).
16. F.M. Wylie, H. Torrance, R.A. Anderson, and J.S. Oliver. Drugs in oral fluid Part I.Validation of an analytical procedure for licit and illicit drugs in oral fluid. Forensic Sci. Int. 150: 191-198 (2005).
17. DHHS. Proposed revisions to mandatory guidelines for federal workplace drug testing programs. Fed. Regist. 69: 19673-19732 (2004).
18. E. Chambers, D.M. Wagrowski-Diehl, Z. Lu, and J.R. Mazzeo. Systematic and comprehensive strategy for reducing matrix effects in LC/MS/MS analyses. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 852: 22-34 (2007).
19. U.S. Department of Health and Human Services. Guidance for the Industry. Bioanalytical MethodValidation. FDA Guidance, CDER, Food and Drug Administration, Center for Drug Evaluation and Research and Center for Veterinary Medicine (CVM) http://www.fda.gov/cder/guidance.